Search research articles
Contact Us
Filters
Showing results (1-10 of 458) with videos related to
Page
of 46
Sort By:
Expert Opinion on Biological Therapy
|
May 29, 2020
Brodalumab in the treatment of chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni
The Journal of International Medical Research
|
September 30, 2016
Glomerular filtration rate in patients with psoriasis treated with etanercept
Paolo Gisondi, Giampiero Girolomoni
Drug Design, Development and Therapy
|
June 17, 2016
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni
The Journal of Investigative Dermatology
|
June 12, 2009
Canine models of atopic dermatitis: a useful tool with untapped potential
Rosanna Marsella, Giampiero Girolomoni
Seminars in Thrombosis and Hemostasis
|
May 20, 2009
Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors
Paolo Gisondi, Giampiero Girolomoni
Autoimmunity Reviews
|
September 15, 2007
Biologic therapies in psoriasis: a new therapeutic approach
Paolo Gisondi, Giampiero Girolomoni
Dermatology (Basel, Switzerland)
|
July 30, 2008
Psoriasis and metabolic comorbidities: the importance of well-designed prospective studies. Commentary
Giampiero Girolomoni, Paolo Gisondi
Vaccines
|
April 28, 2023
Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases
Andrea Chiricozzi, Giampiero Girolomoni
The Journal of Dermatological Treatment
|
October 30, 2016
Patients' perspectives in the management of psoriasis: the Italian results of the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey
Paolo Gisondi, Giampiero Girolomoni
Dermatology and Therapy
|
June 4, 2026
Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study
Paolo Gisondi, Giampiero Girolomoni
Page
of 46
Search research articles
Search
Showing results (1-10 of 458) with videos related to
Sort By:
Page
of 46
Expert Opinion on Biological Therapy
|
May 29, 2020
Brodalumab in the treatment of chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni
The Journal of International Medical Research
|
September 30, 2016
Glomerular filtration rate in patients with psoriasis treated with etanercept
Paolo Gisondi, Giampiero Girolomoni
Drug Design, Development and Therapy
|
June 17, 2016
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni
The Journal of Investigative Dermatology
|
June 12, 2009
Canine models of atopic dermatitis: a useful tool with untapped potential
Rosanna Marsella, Giampiero Girolomoni
Seminars in Thrombosis and Hemostasis
|
May 20, 2009
Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors
Paolo Gisondi, Giampiero Girolomoni
Autoimmunity Reviews
|
September 15, 2007
Biologic therapies in psoriasis: a new therapeutic approach
Paolo Gisondi, Giampiero Girolomoni
Dermatology (Basel, Switzerland)
|
July 30, 2008
Psoriasis and metabolic comorbidities: the importance of well-designed prospective studies. Commentary
Giampiero Girolomoni, Paolo Gisondi
Vaccines
|
April 28, 2023
Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases
Andrea Chiricozzi, Giampiero Girolomoni
The Journal of Dermatological Treatment
|
October 30, 2016
Patients' perspectives in the management of psoriasis: the Italian results of the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey
Paolo Gisondi, Giampiero Girolomoni
Dermatology and Therapy
|
June 4, 2026
Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study
Paolo Gisondi, Giampiero Girolomoni
Page
of 46